What is Bicara Therapeutics's occupancy and related charges?

Bicara Therapeutics (BCAX) reported occupancy and related charges of $500K in Q2 2025.

Bicara Therapeutics BCAX Occupancy and Related Charges

Occupancy and Related Charges at other companies

TMC the metals company Inc.TMC

$477K0.0%

Oruka Therapeutics, Inc.ORKA

$200K+100%

The BancorpTBBK

$1.28M-5.6%

EOG ResourcesEOG

$462M+15.2%

Digital RealtyDLR

$694.13M+13.7%

Target HospitalityTH

$2.15M+5.2%

Other financials

Income statement

See full

Operating income-$60.2M-44.2%

Net income-$56.2M-52.6%

EPS (diluted)-$0.93-36.8%

Balance sheet

See full

Cash & equivalents$323.5M-30.0%

Total debt$1.4M+144%

Total equity$514.0M+12.0%

Total assets$553.6M+15.8%

Cash flow

See full

Operating cash flow-$37.5M-33.5%

CapEx$60.0K—

Free cash flow-$37.6M-33.7%

Valuation

See full

Market cap$1.68B+81.4%

Returns & leverage

See full

Return on equity-32.3%—

Debt / equity0×0.0×

Current ratio13.9×-10.8×

Where this comes from

Reported directly by Bicara Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseExpense.

The official record: Bicara Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bicara Therapeutics's occupancy and related charges.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Bicara Therapeutics's occupancy and related charges?: Bicara Therapeutics (BCAX) reported occupancy and related charges of $500K in Q2 2025.